A: Atezolizumab (Recombinant) Injection (1,200 Mg 20 Ml/Bottle) 210 Bottles, B: Emicizumab (Recombinant) Injection (90 Mg 0.6 Ml/Bottle) 60 Bottles, C: Emicizumab (Recombinant) Injection (105 Mg 0.7 Ml/Bottle) 70 Bottles

  Address - Japan

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102151414

  Document Type - Tender Notices

Description - Description: Tender announcementThe following will be open to public competitive bidding.January 24, 2025National University Corporation Hirosaki UniversityContract Officer: Kenichi Hakamada, Director of the Faculty of Medicine Hospital◎Procurement agency number: 415 ◎Location number: 021. Procurement details⑴ Item classification number: 4⑵ Purchase item and quantityA Atezolizumab (recombinant) injection (1,200 mg 20 ml/bottle) 210 bottlesB Emicizumab (recombinant) injection (90 mg 0.6 ml/bottle) 60 bottlesC Emicizumab (recombinant) injection (105 mg 0.7 ml/bottle) 70 bottles⑶ Characteristics of procurement item, etc.: See bidding instructions.⑷ Delivery period: April 1, 2025 to

Gt Ref Id - 102151414

Deadline - Feb 08, 2025